Effects of Chronic Nicotine Infusion on Kinetics of High‐Affinity Nicotine Binding

Abstract: It is well established that chronic nicotine treatment produces a dose‐dependent increase in high‐affinity l‐[3H]nicotine binding. This increase may be due to chronic desensitization of the receptor. Sophisticated kinetic analyses of high‐affinity nicotine binding to rat brain have demonstrated that the association rate is biphasic; the fast phase may represent binding to a high‐affinity predesensitized state and the slow phase may represent binding to a lower affinity ground state that then isomerizes to form the high‐affinity binding site. This isomerization presumably leads to receptor desensitization. The studies reported here assessed whether binding to mouse brain nicotinic receptors shows these same properties and whether chronic intravenous infusion of nicotine results in changes in these kinetic properties. The results obtained indicate that mouse brain nicotine binding also shows biphasic association kinetics and uniphasic dissociation kinetics, which supports the assertion that the receptor exists in two interconvertible states. However, unlike other results obtained with rat brain, the rate of the slow association process did not change with ligand concentration. Chronic infusion resulted in a dose‐dependent increase in l‐[3H]‐nicotine binding, but the ratio of fast/slow phases of binding was not changed by these treatments. These results suggest that chronic infusion does not alter measurably the kinetics of nicotinic receptor binding when measured in vitro.

[1]  A. C. Collins,et al.  Downregulation of nicotinic receptor function after chronic nicotine infusion. , 1993, The Journal of pharmacology and experimental therapeutics.

[2]  S. Heinemann,et al.  The expression of nicotinic acetylcholine receptors by PC12 cells treated with NGF , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[3]  S. Rogers,et al.  A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment. , 1992, Molecular pharmacology.

[4]  A. C. Collins,et al.  Genotype influences the development of tolerance to nicotine in the mouse. , 1991, The Journal of pharmacology and experimental therapeutics.

[5]  A. C. Collins,et al.  Regulation of Brain Nicotinic Receptors by Chronic Agonist Infusion , 1991, Journal of neurochemistry.

[6]  R. Lukas Effects of Chronic Nicotinic Ligand Exposure on Functional Activity of Nicotinic Acetylcholine Receptors Expressed by Cells of the PC12 Rat Pheochromocytoma or the TE671/RD Human Clonal Line , 1991, Journal of neurochemistry.

[7]  A. C. Collins,et al.  Dissociation of the apparent relationship between nicotine tolerance and up-regulation of nicotinic receptors , 1990, Brain Research Bulletin.

[8]  S Wonnacott,et al.  The paradox of nicotinic acetylcholine receptor upregulation by nicotine. , 1990, Trends in pharmacological sciences.

[9]  A. C. Collins,et al.  Purification of L-[3H]nicotine eliminates low affinity binding. , 1990, Life sciences.

[10]  M. Benwell,et al.  Evidence that Tobacco Smoking Increases the Density of (−)‐[3H]Nicotine Binding Sites in Human Brain , 1988, Journal of neurochemistry.

[11]  A. C. Collins,et al.  Dose-response analysis of nicotine tolerance and receptor changes in two inbred mouse strains. , 1986, The Journal of pharmacology and experimental therapeutics.

[12]  A. C. Collins,et al.  Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and alpha-bungarotoxin. , 1986, Molecular pharmacology.

[13]  A. Collins,et al.  Nicotine-induced tolerance and receptor changes in four mouse strains. , 1986, The Journal of pharmacology and experimental therapeutics.

[14]  R. D. Schwartz,et al.  In Vivo Regulation of [3H]Acetylcholine Recognition Sites in Brain by Nicotinic Cholinergic Drugs , 1985, Journal of neurochemistry.

[15]  R. Mcgee,et al.  Agonist-induced regulation of the neuronal nicotinic acetylcholine receptor of PC12 cells. , 1985, Molecular pharmacology.

[16]  R. D. Schwartz,et al.  Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo. , 1983, Science.

[17]  A. Goldstein,et al.  Stereospecific nicotine receptors on rat brain membranes. , 1980, Science.

[18]  S. Sharpless,et al.  Techniques for the chronic cannulation of the jugular vein in mice , 1979, Pharmacology Biochemistry and Behavior.

[19]  B. Katz,et al.  A study of the ‘desensitization’ produced by acetylcholine at the motor end‐plate , 1957, The Journal of physiology.